Mice deficient in the interferon consensus sequence binding protein (ICSBP) develop a disease resembling chronic myeloid leukemia (CML), which in humans is caused by the BCR/ABL oncoprotein. Interferon-alpha (IFN-alpha) induces ICSBP expression and is an effective therapy for CML, This study examined whether enforced expression of ICSBP might antagonize BCR/ABL-induced leukemia; results demonstrated that ICSBP-modified cells generated a protective CD8(+) cytotoxic T-cell response against BCR/ABL-transformed BaF3 cells in a murine leukemia model. ICSBP expression represents a novel means of stimulating a host immune response to BCR/ABL(+) leukemia cells and a potential strategy for immunotherapy of CML. (Blood, 2001;97:3491-3497) (C) 2001 by The American Society of Hematology.
机构:
City Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USACity Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USA
Bhatia, R
;
Verfaillie, CM
论文数: 0引用数: 0
h-index: 0
机构:
City Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USACity Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USA
机构:
City Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USACity Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USA
Bhatia, R
;
Verfaillie, CM
论文数: 0引用数: 0
h-index: 0
机构:
City Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USACity Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USA